# Day One Biopharmaceuticals, Inc. (DAWN) — merger [completed]
Source: sec.gov · situation sit_703b100cb894123d8f7e · public 6397696497861782449 · retrieved 2026-08-21T15:10:58.551Z

## Overview
Day One Biopharmaceuticals, Inc., or the Company or Day One, is a biopharmaceutical company dedicated to developing and commercializing targeted therapies for people of all ages with life-threatening diseases.

## Key dates
- Announced 2026-04-08 · Completed 2026-03-26

## Timeline
- 2026-03-26 · SC 14D9 (0001193125-26-125045): SC 14D9 - Day One Biopharmaceuticals, Inc. — *Day One Biopharmaceuticals, Inc., or the Company or Day One, is a biopharmaceutical company dedicated to developing and commercializing targeted therapies for people of all ages with life-threatening diseases.* Relationship with the Servier Parties Merger Agreement On March 6, 2026, Day One, Parent, Purchaser and Servier entered into the Merger Agreement. Section 11 of the Offer to Purchase, which contains a summary of the material provisions of the Merger Agreement, and Section 15 of the Offer to Purchase, which contains a description of the conditions of the Offer, are each incorporated herein by reference.
  https://www.sec.gov/Archives/edgar/data/1845337/0001193125-26-125045.txt
- 2026-04-08 · SC 14D9/A (0001193125-26-146181): SC 14D9/A - Day One Biopharmaceuticals, Inc. — *Day One Biopharmaceuticals, Inc., or the Company or Day One, is a biopharmaceutical company dedicated to developing and commercializing targeted therapies for people of all ages with life-threatening diseases.*
  https://www.sec.gov/Archives/edgar/data/1845337/0001193125-26-146181.txt
- 2026-04-14 · SC 14D9/A (0001193125-26-153722): SC 14D9/A - Day One Biopharmaceuticals, Inc. — *Day One Biopharmaceuticals, Inc., or the Company or Day One, is a biopharmaceutical company dedicated to developing and commercializing targeted therapies for people of all ages with life-threatening diseases.*
  https://www.sec.gov/Archives/edgar/data/1845337/0001193125-26-153722.txt
- 2026-04-23 · SC 14D9/A (0001193125-26-171975): SC 14D9/A - Day One Biopharmaceuticals, Inc. — *Day One Biopharmaceuticals, Inc., or the Company or Day One, is a biopharmaceutical company dedicated to developing and commercializing targeted therapies for people of all ages with life-threatening diseases.*
  https://www.sec.gov/Archives/edgar/data/1845337/0001193125-26-171975.txt

## Citations
- 0001193125-26-125045 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000119312526125045
- 0001193125-26-146181 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000119312526146181
- 0001193125-26-153722 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000119312526153722
- 0001193125-26-171975 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000119312526171975